Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 91-97, April 2010

Adverse effects of drugs on the esophagus

  • Radu Tutuian (Clinical Lead Outpatient Services and Gastrointestinal Function Laboratory)

      Affiliations

    • Corresponding Author InformationTel.: +41 31 632 2111; fax: +41 31 632 4861.

Division of Gastroenterology, University Clinics of Visceral Surgery and Medicine, Bern University Hospital, Inselspital Bern, CH-3010 Bern, Switzerland

Given the function of the esophagus to transport orally ingested solids and liquids into the stomach there are several medications with adverse effect on esophageal structures and function. Various pharmacologic agents can induce esophageal injury, promote gastroesophageal reflux by decreasing lower esophageal sphincter tone or affect esophageal perception and motility. The risks of bisphosphonates, doxycycline, ferrous sulfate, ascorbic acid, aspirin/NSAIDs and chemotherapeutic agents to induce esophageal lesions have been documented in case reports and short series. In addition to direct mucosal injury, many commonly used medications including nitroglycerins, anticholinergics, β-adrenergic agonists, aminophyllines, and benzodiazepines promote/facilitate gastroesophageal reflux by reducing lower esophageal sphincter pressure. Additional evidence accumulates on the adverse effects of various medications on esophageal motility and perception.

The treatment of medication-induced esophageal lesions includes (1) identifying and discontinuing the causative medication, (2) promoting healing of esophageal injury by decreasing esophageal acid exposure or coating already existing esophageal lesions, (3) eventual use of protective compounds.

Keywords: Pill esophagitis, Medication-induced reflux, Esophageal dysmotility, Lower esophageal sphincter

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6918(10)00019-3

doi:10.1016/j.bpg.2010.02.005

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 2 , Pages 91-97, April 2010